The scope of this report is limited to evaluating drug stability with respect to spaceflight. The effects of spaceflight on drug pharmacokinetics (PK) or drug pharmacodynamics (PD) are not addressed in this report: these topics will be reviewed in future reports. This is the first report of the available evidence pertaining to the chemical and physical stability of drugs in the context of drug impurity, drug repackaging, and exposure to ionizing space radiation. Previous studies are discussed within this report and, where possible, the data are interpreted and contextualized with regards to drug stability.


    Zugriff

    Zugriff über TIB

    Verfügbarkeit in meiner Bibliothek prüfen


    Exportieren, teilen und zitieren



    Titel :

    Evidence Report: Risk of Ineffective or Toxic Medication During Long-Duration Exploration Spaceflight


    Beteiligte:

    Erscheinungsdatum :

    20.12.2023


    Medientyp :

    Sonstige


    Format :

    Keine Angabe


    Sprache :

    Englisch


    Schlagwörter :


    Future Improvements to Impact for Long Duration Exploration Spaceflight

    E Stratton / J G Steller / D Levin et al. | NTRS


    Plasma Cytokine Levels During Long-Duration Spaceflight

    Crucian, Brian E. / Zwart, Sara R. / Quiriarte, Heather A. et al. | NTRS | 2011


    Submacular Choroid Thickness Increases During Long-Duration Spaceflight

    Laurie, Steven S. / Macias, Brandon R. / Ferguson, Connor R. et al. | NTRS | 2018


    Assessment of Hematologic Parameters During Long Duration Spaceflight

    Kunz H. / Quiriarte H. / Ploutz-Snyder R. et al. | NTIS | 2016


    Personal growth following long-duration spaceflight

    Suedfeld, Peter | Online Contents | 2012